Global Statistics

spot_img

Conference Coverage

SITC 2025: Data Shows Promising Preclinical Results for SynKIR™-110 in Solid Tumors

New preclinical data from Verismo Therapeutics' lead clinical pipeline, SynKIR™-110, targeting mesothelin in solid tumors, were presented at the Society of Immunotherapy of Cancer...

Verismo Therapeutics to Present Updated Study Results at SITC and ASH

During the upcoming Society of Immunotherapy in Cancer (SITC) 2025 Annual Meeting, held November 7-9, 2025, and during the American Society of Hematology (ASH)...

Recordati Rare Diseases to Share New Data at the American Society of Hematology (ASH) Meeting

Recordati Rare Diseases Inc. today announced the presentation of new data related to its growing portfolio of treatments for rare hematologic disorders at the...

Recent Articles

Stay on op - Ge the daily news in your inbox

spot_img